Page last updated: 2024-11-12
triphenylphosphine gold chloride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 10874691 |
| SCHEMBL ID | 1450566 |
| MeSH ID | M0067012 |
Synonyms (21)
| Synonym |
|---|
| 14243-64-2 |
| chloro(triphenylphosphine)gold(i), >=99.9% trace metals basis |
| triphenylphosphine gold chloride |
| chloro(triphenylphosphine)gold |
| A807907 |
| chlorogold; triphenylphosphane;chloro(triphenylphosphine)gold(i) |
| triphenylphosphinechlorogold |
| SCHEMBL1450566 |
| FT-0637040 |
| aucl(pph3) |
| chloro(triphenylphosphine)gold(i) |
| chloro(triphenylphosphine)gold(i), premion? |
| mfcd00009588 |
| chlorogold; triphenylphosphane |
| J-007651 |
| SY009694 |
| Q5102990 |
| chloro(triphenylphosphane)gold(i) |
| chlorogold;triphenylphosphane |
| T71763 |
| chlorotriphenylphosphinegold(i), 98% |
Research Excerpts
Bioavailability
| Excerpt | Reference | Relevance |
|---|---|---|
| " This suggests that the extent of modification of the protein in vivo may have an important influence on the transport and bioavailability of gold antiarthritic drugs." | ( A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin. Beck, JL; Ralph, SF; Talib, J, 2006) | 0.33 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 21.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.41) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||